Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-104823
Filing Date
2024-09-10
Accepted
2024-09-09 17:34:56
Documents
2
Period of Report
2024-09-09

Document Format Files

Seq Description Document Type Size
1 6-K press_release_sept_9_202.htm 6-K 21182
2 EX-99.1 ipa-ex99_1.htm EX-99.1 21679
  Complete submission text file 0000950170-24-104823.txt   43893
Mailing Address 3204-4464 MARKHAM ST. VICTORIA A1 V8Z 7X8
Business Address 3204-4464 MARKHAM ST. VICTORIA A1 V8Z 7X8 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 6-K | Act: 34 | File No.: 001-39530 | Film No.: 241288145
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)